|Report of the Study of the “Dr. Michaels” Topical Product Family in Psoriasis||Australia||Dr. Thomas Smith – Monash University|
|Prospective, Randomised Placebo-Controlled Double-Blind Study – Chronic Plaque Psoriasis, Journal of the European Academy of Dermatology and Venereology||Austria||Prof. H. Maier – Department of Dermatology, Medical University of Vienna, Vienna, Austria.|
|New Complementary Treatment for Psoriasis||Romania/ Hungary||Dept. of Dermato-Venereology, Semmelweis University, and Dept. of Dermatology, KOLOZSVAR – ROMANIA.|
|Dr. Michaels’ topical product family in psoriasis||Hungary||Prof. Dr. Attila Horvath – Dept. of Dermato-Venereology, Semmelweis University.|
|Clinical Examination of the Efficacy of Preparations Dr. Michael in the Treatment of Cases of Psoriasis with Deferring Severity||Russia||Prof. N.G. Korotky – Head of the Department of Dermatology and Venereology of the Paediatric Clinic at the Russian State Medical University.|
|The Results Of Attestation Study Of Effectiveness – Dr. Michaels Psoriasis Products (undertaken during the years 2005-2008)||Czech Rep.||Head Physician MUDr. Štepánka Capková, Faculty Hospital Motol. MUDr. Michaela Havlícková, Faculty Hospital Královské Vinohrady. Prof. MUDr. Karel Pizinger, Faculty Hospital in Plzen. Head Physician MUDr. Jaroslav Hoffmann, Central Military Hospital in Praha. Doc. MUDr. Karel Ettler, CSc. Faculty Hospital in Hradec Králové. Head Physician MUDr. Hana Duchková, DrSc. Dermatology Sanatorium in Ústí nadLabem. Head Physician MUDr. Hana Bucková, Ph.D. Faculty Hospital in Brno. Head Physician MUDr. Hana Zelenková, Ph.D. DOST – Svidník, Slovensko(Slovakia). Prof. MUDr. František Novotný, DrSc. Prague Dermatology Center. Prof. MUDr. Jana Hercogová, CSc. Faculty Hospital Bulovka.|
|Study about efficacy of Dr.Michaels pharmaceuticals in psoriasis in sanitorium of Prof. Novotný.||Czech Rep.||Prof. MUDr. František Novotný, DrSc. Prague Dermatology Center.|
|To investigate whether Dr. Michaels product family is comparable to Advantan – methylprednisolone aceponate (MPA) as a viable alternative treatment option for the treatment and management of Stable Chronic Plaque Psoriasis. Comparative Study – 2009||China||Professor Lee Feng – Head of the Department of Dermatology and Venereology, Southern Medical University (Guang Dong).|
Report of the study of the “Dr Michaels” topical product family in psoriasis. (Australian Trial)
“Prospective, randomized placebo-controlled double-blind study on the efficacy and safety of a series of herbal skin-care products for stable chronic plaque psoriasis.”
Dermatology, Medical University of Vienna, Vienna, Austria, Dermatology, Psoriasis & Skin Clinic, Melbourne, Australia, and was published in the Journal of the European Academy of Dermatology and Venereology, Volume 18. Number 6, November 2004. P061.
Background: Among patients with psoriasis concern is growing about possible side effects of long-term steroid therapy and more and more of them turn to complementary treatment options.
Czech Republic Trial
Study about Efficacy of Dr Michaels Pharmaceuticals in Psoriasis in Sanatorium of Prof. Novotný in Prague.
“The goal of the study was verification of the efficacy of Dr Michaels remedies in selected patients suffering from psoriasis…..The comparative tests have monitored status and therapy before Dr Michaels treatment. This fact is described in 10 patients under review….We evaluate the results of therapy by Dr Michaels remedies on average on 90% namely not only in 10 cases monitored in the study, but in additional 65 cases treated in our clinic by these remedies…” Prof. Novotný.
“Evaluation of the Dr Michaels topical product family in psoriasis, to determine its efficacy, adverse effects and tolerability.”
“Based on the results of this study, the Dr Michaels product family can be successfully applied in mild to moderately severe psoriasis.”
“These preparations due to the simultaneous operation of oiling and moisturizing, the absence, in most cases, the occurrence of side effects, can be used for a long time and recommended for long-term care of the skin in patients with psoriasis.”
“Trials were conducted at Department of Dermatology, SEMMELWEIS UNIVERSITY, BUDAPEST and at Department of Dermatology, KOLOZSVAR, ROMANIA”
“95% of the patients stated that they would continue to use the product due to it’s effectiveness, including those who had only moderate improvement.”
Clinical examination of the efficacy of preparation Dr Michael topicals in the treatment of cases of psoriasis with differing severity.
“This treatment method is highly effective and, in terms of efficacy, it is comparable to the generally used therapeutic regimen which is based on the application steroid ointments with fluoride content.”
“Dr Michael’s preparations do not have severe side effects, they are user-friendly, they do not have an unpleasant smell, and they do not stain the underwear and can successfully be applied in the case of outpatients as well.”
The Results Of Attestation Study Of Effectiveness Dr. Michaels Psoriasis Products (undertaken during the years 2005-2008)
Conducted by Prof. MUDr. Jana Hercogová, CSc.
Summary results of tests on 203 patients. Very good results were achieved with chronic psoriasis, whereas in acute stages the good results were not often delivered.
The following specialists participated in this study:
|S.No||Name of Doctor / Professor||Hospital/Institution|
|1||Head Physician MUDr. Št?pánka ?apková||Faculty Hospital Motol|
|2||MUDr. Michaela Havlí?ková||Faculty Hospital Královské Vinohrady|
|3||Prof. MUDr. Karel Pizinger||Faculty Hospital in Plze?|
|4||Head Physician MUDr. Jaroslav Hoffmann||Central Military Hospital in Praha|
|5||Doc. MUDr. Karel Ettler, CSc.||Faculty Hospital in Hradec Králové|
|6||Head Physician MUDr. Hana Duchková, DrSc||Dermatology Sanatorium in Ústí nad Labem|
|7||Head Physician MUDr. Hana Bu?ková, Ph.D.||Faculty Hospital in Brno|
|8||Head Physician MUDr. Hana Zelenková, Ph.D||DOST – Svidník, Slovensko (Slovakia)|
|9||Prof. MUDr. František Novotný, DrSc.||Prague Dermatology Center|
|10||Prof. MUDr. Jana Hercogová, CSc.||Faculty Hospital Bulovka|
* Prof. Novotný was monitoring patients during the years 2005–2008. The results from other dermatology workplaces come from tests conducted during the year 2008.
Average success ratio: 82.3%